BASI Financial Facts

Diluted net income (loss) per share: -0.02
Basic net income (loss) per share: -0.02
See Full Income Statement

Revolving line of credit: 813K
Accumulated other comprehensive income: 84K
See Full Balance Sheet

Earnings History for Bioanalytical Systems (BASI)

  |   Expand Research on BASI
Next EPS Date 8/15/13 *Est. EPS Growth Rate +80.0% *Last Qtr.
Average EPS % Beat Rate -267.9% Revenue Growth Rate -28.2% *Last Qtr.
Average % Move 1-Wk after EPS +10.9%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/15/13 Q213 -$0.02$0.01 -$0.03$5.16M$5.74M N/A / N/A N/A +23.2% Details
2/14/13 Q113 $0.02-$0.03 +$0.05$5.8M$6.65M N/A / N/A N/A -11.5% Details
12/27/12 Q412 -$0.32-$0.03 -$0.29$6.54M$7.07M N/A / N/A N/A +14.1% Details
5/11/12 Q212 -$0.27$0.07 -$0.34$6.97M$8.88M N/A / N/A N/A +28.3% Details
8/14/12 Q212 -$0.10-$0.14 +$0.04$7.19M$7.23M N/A / N/A N/A +48.1% Details
2/10/12 Q112 -$0.21N/A N/A $7.52M$8.1M N/A / N/A N/A +18.5% Details
12/20/11 Q411 -$0.10N/A N/A $8.15M$7.41M N/A / N/A N/A +4.1% Details
5/12/11 Q211 $0.10N/A N/A $8.4M$6.9M N/A / N/A N/A -17.2% Details